Categories

Angie Szumlinski
|
February 9, 2021
Bamlanivimab Prevented COVID-19 in BLAZE-2 Trial

Angie Szumlinski
|
February 9, 2021
Background Checks

Angie Szumlinski
|
February 9, 2021
Skin Failure vs Pressure Injury

Angie Szumlinski
|
February 8, 2021
FDA Letter of Authorization- Reissuance of Convalescent Plasma
Stay informed with Angie’s expert perspective on current clinical challenges, industry trends, and real-world risk insights.
